Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.9213
-0.0487 (-5.02%)
Mar 28, 2025, 4:00 PM EST - Market closed
Kairos Pharma Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.50
Upside
+605.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +334.17% | Mar 27, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Mar 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Feb 26, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Feb 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Feb 12, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Jan 22, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +876.88% | Nov 14, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +876.88% | Oct 14, 2024 |